Most of the estimated 40 million blind individuals in the world are in the older age groups. Data on blindness and visual impairment are primarily from blindness registries and prevalence surveys in different countries throughout the world. The quality of these data vary tremendously from one country to another, and com parability of the results from different studies is difficult. However, all studies indicate an increase in the prevalence of visual loss and blindness with increasing age. Cataract is the most prevalent eye disease in the world and is a major cause of visual loss in developing as well as in developed countries. Other major eye diseases in the elderly include age related macular degeneration, glaucoma, and diabetic retinopathy. A number of risk factors have been suggested for cataract, age related macular degeneration, and glaucoma, yet few have been well established. Certain factors for these conditions are similar, including age, hypertension, prolonged exposure to sunlight, and nutritional factors such as Vitamin E. Epidemiologic studies are needed to define the risk factors for these different eye diseases with the goal of decreasing risk of disease and possible disease prevention, as well as developing better estimates of the magnitude of the problems of visual loss and eye diseases in the elderly.
The total number of blind individuals throughout the world has been estimated to be as high as 40 million. ! In both developing and developed countries the majority of these blind individuals are in the older age groups. With increasing numbers of individuals now reaching the age of 60 years and older, the numbers of visually impaired persons will also increase. This will create needs for additional services, programmes, and treatment for the visually impaired. Therefore, it is important to determine the magnitude of the problem in different countries, as well as globally. Identi fication of the specific causes of visual loss and blindness is essential in order to develop appropriate treatment, rehabilitation, and service programmes. In addition, identifica tion of risk factors for the major causes of blindness is needed to develop measures for prevention of visual impairment.
The objectives of this discussion are to: (1) define the magnitude of visual impair ment, visual loss, and blindness in the elderly;
(2) describe the epidemiologic characteristics of the leading causes of eye disease in the elderly (e.g. cataracts, age related macu lar degeneration (AMD), glaucoma, dia betic retinopathy); (3) discuss possible risk factors for cataracts, age related macular degeneration and glaucoma; and Figure 1 clearly indicates a dramatic increase in the prevalence rate per 1,000 of those individuals who registered as blind in Oxford, England in 1966. According to these data, the prevalence of blindness registration increases approximately 20 times between the ages of 65 and 90, with the blind ness rate increasing from approximately 0.5 per cent at age 65 to as high as 10 per cent over the age of 90. These rates are similar for both males and females. 3 A second source of data on the prevalence of visual impairment, blindness, and eye disease in the elderly is prevalence studies. Three major population based studies pub lished in recent years have provided infor mation on the prevalence of visual impairment and vision loss and on the causes of vision loss in the United States. They are known as the National Health Interview Sur vey (HIS),10 the Framingham Eye Study (FES),l1 and the National Health and Nutri tion Examination Survey (NHANES),12 and will be discussed later. Prevalence studies that have been published from other countries include one in Iceland on legal blindness,13 one in New Zealand on ocular disease in indi viduals 65 years and 01der,14 and one in Nepal on blindness and cataract prevalence.7 As with the blindness registries, findings from these different studies are not usually compar able to one another because of different defi nitions of visual impairment and specific eye conditions and different methods of evaluat ing vision loss.
Data from the HIS, 1983 are presented in Table I . This survey is an ongoing cross-sec tional household interview survey that started in 1957 on a sample of the civilian, non-institu tionalised United States population. It pro vides national data on the prevalence of chronic conditions and impairments as well as Table III shows that in blindness registries for (1) the data only reflect those who register as legally blind; (2) the proportion who register probably var ies from one country to another; and (3) the classification of the cause of blindness is not done in a standardised way. These limitations obviously affect the accuracy of the data. However, these data may be useful in providing relative frequen cies for causes of visual loss within each registry.
The tremendous variation in the percentage of persons who are blind from AMD among the different registries may be due, at least in part, to the varying diagnostic criteria used. However, it is also possible that the differ ences are real.
The decrease in the percentage of persons blind from cataract (from 23 per cent in England and Wales, 1955-1962, to 10 per cent in the west of Scotland in 1980) may reflect, at least in these countries, a dramatic increase in the number of cataract operations performed between 1962 and 1980. This decrease would probably not be as apparent in countries such as India where access to treatment is limited.
The proportion blind from glaucoma is rela tively constant among the different studies. The proportion blind from diabetic retinopa thy is similar for England and Wales, Canada, and the west of Scotland. It may be slightly higher in the United States because of the method of classifying these SUbjects. In con trast to these chronic and age related causes of blindness in western nations, many causes of blindness in African and Asian countries are infectious in origin, such as trachoma and onchocerciasis, and more younger people are affected.9 •15 A. Cataract Cataract is the primary cause of blindness in 116 countries covered by the Blindness Data Bank which is a component of the WHO Pro gramme for the Prevention of Blindness. It is estimated to cause severe loss of vision in 40.4 per cent of an estimated 42 million blind per sons worldwide, with 13 million being in developing countries and 4 million being in developed countries. 16 Because cataract is prevalent in developing as well as developed countries, it is the only ocular condition which is a leading blinding condition in all countries of the world. It is particularly prevalent in developing countries in the tropical areas and accounts for 30-50 per cent of vision loss in various African countries not endemic for tra choma or onchocerciasis. 16 While in certain areas of Asia and Africa cataract appears to have an earlier onset than in other places, all countries with available data show that prevalence increases with age. Table IV presents data collected as part of the Nepal Blindness Survey in 1981 on the preva lence of cataract of senile or undetermined aetiology by age and sex. For the purposes of this study, cataract cases were defined as per sons diagnosed by an ophthalmologist to have lenticular opacities of undetermined cause in either or both eyes (incipient, immature, or mature cataracts) or as persons who were aphakic or had after-cataract membranes. These rates are based on a total of 956 males and 982 females over the age of 60; 138 males and 117 females were 75 years and older. Prevalence increases with increasing age; the increase is 3-fold for males and approximately double for females between the ages of 60-64 years and 75 years and older. These data show a consistently higher cataract prevalence for females than males in each age group, and beginning at the age group of 60-64 years, one-quarter of the Nepalese women have some degree of cataract. By the age of 75, more than half of the female population has developed cataracts. 17 Table V 18 Two drawbacks to this study are that (1) only 70 per cent of the selected population received eye examinations; and (2) assessment of the diagnoses may be unre liable because of the larger number of examiners with diverse levels of experi ence and training. However, the NHANES data have provided the first national estimates for cataracts and other eye conditions and have proved to be useful as guidelines for prevalence estimates.
Leske and Sperduto have reviewed the epi demiology of senile cataract extensively. This paper will describe briefly their discussion of possible risk factors. 19 There have been rela tively few epidemiologic studies investigating risk factors for senile cataracts despite its high frequency. However, these studies have identified a number of factors as being associated with senile cataracts or lens opacities, some of which have been identified more consistently than others. These factors, which are pre sented in Table VI , have been grouped into three categories of demographic factors, other host factors, and environmental factors. The demographic factors are age, sex, and geographic. The association of cataracts with increasing age has been consistently docu mented in numerous studies. Regarding sex or gender as a possible risk factor, blindness registry data in the U. S. 5 and England2 have shown senile cataract blindness to be more common among women than men; prevalence studies in the U. S. (NHANES, 18 FESIO) , Scot land,4 and NepaP? have also demonstrated cataracts to be more frequent among females. Studies on cataract prevalence conducted throughout the world have indicated tremen dous variation in its frequency in different countries and in different regions within a country such as India, with cataracts being most common in developing countries in trop ical areas. These variations in cataract fre quency may be real and thus be due to genetic or environmental factors, or they may be artifactual due to differences in disease defi nitions, study methodology, and availability of medical services. 19 The category of other host factors includes those of diabetes mellitus, high blood pres sure, nutritional factors such as proteins, tryp tophan and other essential amino acids, riboflavin, selenium, and calcium, and family cataract history. Of these factors, the associ ation of cataracts and diabetes has been studied most extensively in hospital based sur veys, as well as in the population based studies of NHANES and FES. The results of these studies tend to support the existence of such an association which seems to be stronger at younger (50-69 years) than older (�70 years) ages. The hypothesis that inadequacy of cer tain nutritional factors contributes to the development of senile cataracts has not yet been documented by clinical or epidemiologic data. However, data from animal studies and some epidemiologic studies suggest a need for additional research in this area. 19 The major environmental factors which have been suggested as possible risk factors the age groups studied,lI but corroborates the finding of no increased prevalence of mild or more severe senile macular changes among females when compared to males. When interpreting these data, one must keep in mind the drawbacks of this study which have been discussed previously. How ever, these results have raised doubts both about the observation in the FES that males are at lower risk of developing AMD than females and the clinical impression that blacks are at lower risk of developing this disease than whites. These observations require further study.
The information on possible risk factors for AMD presented in Table IX comes mainly from the FES, NHANES, and a number of case-control, clinical, and animal studies. These factors have been grouped for the pur poses of the present discussion into the cate gories of demographic, other host, and environmental factors, which are the same used for the cataract discussion. The only factor consistently found to be associated with AMD in all studies is that of age. AMD preva lence increases with increasing age, and there is a rapid increase in prevalence among per sons 65 years and older. II As previously dis cussed, the question of whether being femalell or being white21.22 increases the risk of developing AMD has been raised by several studies and requires further investigation.
Regarding other host factors, each of the following factors have been identified by one or more studies as being associated with AMD: high blood pressure,18,24-26 history of cardiovascular disease,27 history of lung infec tion,24 left ventricular hypertrophy,24 decreased vital capacity,24 blue or medium pigmented iris colour,27,28 hyperopia,25,27,29 decreased hand grip strength ,24,27 short height,24 family history of AMD,27 dermal elastosis,30 and nutritional factors such as Vitamins E and C. 31,32 Of these, high blood pressure, cardiovascular disease history, light or medium iris colour, hyperopia, decreased hand grip strength, family history of AMD, and certain nutritional factors appear most likely to be correlated with this condition.
The association between AMD and high systolic and diastolic blood pressure and hypertension history was found by the Fra mingham Eye Study in 1977, 24 Further ana lyses of these data published recently by Sperduto and Hiller also showed a steady increase in the degree of this association with increased duration of hypertension, which raises the possibility that hypertension at an early age may increase AMD risk. 33 The NHANES also identified a slightly higher mean systolic blood pressure for AMD cases than non-cases, although the statistical signifi cance of this association was not consistent among all age-sex-race categories. 18 One case control study by Delaney and Oates of 50 cases and age-sex matched controls found an association between AMD and antihyperten sive drug use;25 another larger case-control study by Hyman et al. found no association between elevated blood pressure, hyper tension history, or use of antihypertensives with AMD. However, they did find AMD to be associated with a history of one or more cardiovascular diseases, including arteriosclerosis, circulatory problems, hyper tension, stroke and/or transient ischaemic attack, myocardial infarction, and angina. 27 The findings of these different studies raise questions about the possibility of a relation ship between AMD and hypertension and/or other cardiovascular diseases and the nature of such an association if it is real.
The suggestion that light iris pigmentation might be associated with an increased risk of developing AMD was initially suggested by the clinical observations that AMD may be less prevalent in blacks than whites. Two case control studies-one by Hyman et al. 27 and one by Weiter28-have provided some data to suggest such an association. While the role that light iris pigmentation might play in the development and/or progression of AMD remains unclear, there is enough evidence to warrant further investigation of this possible association.
Hyperopia25,27,29 and decreased hand grip strength24.27 have been identified as associated factors in at least two studies. The nature of the relationship between these factors and the development of AMD remains unclear and should be studied further.
Family AMD history was identified as a positive risk factor for AMD by the Hyman case-control study, with AMD cases demon strating a three-fold excess risk of having AMD if a parent or sibling also had the diseaseY The environmental factors which have been suggested as possible risk factors for AMD are cigarettes,27 chemicals (e. g. occupational exposures),27 and prolonged exposure to sun light. 34 These factors have been suggested by epidemiologic and/or clinical studies and should be investigated further.
C. Glaucoma
Glaucoma is the third leading cause of eye disease among the elderly although the mag nitude of its impact on blindness, particularly in individuals over 75 years, is much less than AMD. In black populations, however, the disease appears to be a major cause of blind ness and presents at an earlier age. Glaucoma is the first cause of blindness in U. S. blacks, and registration for glaucoma blindness is eight times higher than in whites. 5 The per cent of blindness due to glaucoma presented in Table X is approximately 15 per cent and 16 Even though blindness from glaucoma may decrease with age the per cent prevalence increases steadily with increasing age. Figure  2 presents data from a study in Gothenburg, Sweden in 1982 and demonstrates an increase from approximately 0. 025 per cent prior to the age of 45 to more than 7 per cent by the age of 80 with the most dramatic increase in preva lence beginning between 65-70 years. 35 Because glaucoma was defined in this study as all residents in Gothenburg under treatment for glaucoma or on a check-up programme after glaucoma surgery in any ophthalmo logical practice or clinic, these results must be regarded cautiously. However, the finding of an increase in prevalence with increasing age was consistent with the observations of other studies such as the FES. ll
Factors that have been suggested as possi bly increasing the risk of glaucoma are sum marised in Table XI . These include the demographic factors of older age, being male, being black, having certain occupations which are based primarily indoors or outdoors, or different geographical locations, and having a positive glaucoma family history. Of these age, male sex, and a positive glaucoma family history have been identified most consistently in different studies and seem most likely to be associated with an increased risk of glaucoma. Systemic factors of diabetes and blood pres sure and ocular factors, including elevated intraocular pressure, enlarged cup/disc ratio, exfoliation syndrome, and high myopia, have also been investigated in numerous studies with varying results. Glaucoma field loss has been associated with high and low levels of blood pressure as well as a sudden decrease in blood pressure. The nature of this association is not well understood and requires further investigation. For further discussion of this Cataract is the most prevalent eye disease in the elderly in the world and is a leading cause of visual loss in developing as well as in devel oped nations. The other major eye diseases in the elderly are AMD, glaucoma, and diabetic retinopathy. Since cataract, glaucoma, and to some extent diabetic retinopathy are treat able, efforts must be made throughout the world to increase access to treatment. While in the U. S. the number of cataract operations has increased dramatically in recent years, similar increases have yet to be seen in coun tries such as India where more than six million persons are blind from cataract. 1 Since the numbers of individuals are increasing in the older age groups as more people are living longer, the prevalence of these eye diseases are expected to increase substantially. Table XIII presents the estimated and the projected per cent increase of cataracts and AMD in the United States between 1970 and 2030 for per sons 55 years and older. 40 These projections estimate almost 300 per cent increases for both of these conditions. Similar predictions were also made for glaucoma and diabetic retinopathy. 40 These increasing numbers stress the need, not only for access to treat ment, but for more efforts towards preven tion, particularly for AMD where no long term treatment is available.
A number of risk factors have been sug gested for cataract, AMD, and glaucoma and certain of these are similar, including age, hypertension, prolonged exposure to sun- light, and nutritional factors such as Vitamin E. Additional studies are needed to define the risk factors for these different diseases with the goal of decreasing risk of disease and poss ible disease prevention. Epidemiology can be extremely useful in accomplishing these goals as well as develop ing better estimates of the magnitude of the problem. Specific contributions can be made by: (1) coordinating international studies with consistent diagnostic criteria to define more clearly the magnitude of the problems; (2) conducting studies to determine risk factors with the goal of possible disease prevention; and (3) conducting clinical trials to determine the best methods of treatment for these dis eases in developing and developed countries. Through the coordinated efforts of epi demiologists, clinicians, and other researchers, the goals of reducing the numbers of individuals with these eye diseases and others causing severe visual loss can begin to be achieved.
